Antibody-drug Conjugate Information
General Information of This Antibody-drug Conjugate (ADC)
| ADC ID |
DRG0NBPZD
|
|||||
|---|---|---|---|---|---|---|
| ADC Name |
Recombinant humanized anti-EGFR mAb-DUO-5 conjugate
|
|||||
| Synonyms |
Recombinant humanized anti-EGFR mAb-DUO-5 conjugate (Zova Biotherapeutics/Zhejiang Hisun Pharmaceutical)
Click to Show/Hide
|
|||||
| Organization |
Zhejiang Zova Biotherapeutics Inc; Zhejiang Hisun Pharmaceutical Co., Ltd.
|
|||||
| Drug Status |
Clinical candidate
|
|||||
| Indication |
In total 2 Indication(s)
Colorectal cancer [ICD11:2B91]
Clinical candidate
Head and neck cancer [ICD11:2B60-2B6E]
Clinical candidate
|
|||||
| Antibody Name |
Undisclosed
|
|||||
| Antigen Name |
Epidermal growth factor receptor (EGFR)
|
Antigen Info | ||||
| Payload Name |
Duostatin 5
|
Payload Info | ||||
| Therapeutic Target |
Human Deoxyribonucleic acid (hDNA)
|
Target Info | ||||
| Linker Name |
Undisclosed
|
|||||
If you find any error in data or bug in web service, please kindly report it to Dr. Shen et al.